Black Walnut

The dosage of Black Walnut varies significantly based on whether it is being used for diagnostic testing, immunotherapy, or as a nutritional supplement.

Diagnostic Testing (Skin Prick Test)

For diagnostic purposes, healthcare providers typically use a concentrated extract (e.g., 1:10 or 1:20 w/v). A single drop is applied to the skin, followed by a puncture. The 'dose' is effectively the minute amount of protein that enters the epidermis. Results are read 15 to 20 minutes after application.

Immunotherapy (Allergy Shots)

In immunotherapy, the dosage follows a 'build-up' phase and a 'maintenance' phase.

• Build-up Phase: Starts with a very dilute solution (e.g., 0.05 mL of a 1:100,000 dilution). Doses are increased weekly or bi-weekly as tolerated by the patient.
• Maintenance Phase: Once the target dose is reached (typically 0.5 mL of a 1:100 or 1:10 dilution), the interval between injections is increased to every 2-4 weeks.

Oral Supplementation

When taken as a dietary supplement, typical adult doses range from 500 mg to 1,000 mg taken one to three times daily. However, there is no standardized FDA-approved dose for the oral consumption of Black Walnut for therapeutic purposes.

Black Walnut extracts are used in children for allergy testing, but extreme caution is required.

• Allergy Testing: Approved for use in children as young as infants, provided the testing is performed by a board-certified allergist. The procedure is identical to adult testing, though fewer sites may be used to minimize distress.
• Immunotherapy: Generally reserved for children aged 5 and older who can communicate symptoms of a systemic reaction.
• Oral Use: Not recommended for children under the age of 12 without direct pediatric supervision due to the lack of safety data regarding its estrogenic and naphthoquinone content.

Renal Impairment

No specific dosage adjustments are provided by manufacturers for patients with kidney disease when using allergenic extracts. However, for oral supplementation, patients with a GFR (Glomerular Filtration Rate) below 30 mL/min should exercise caution, as the elimination of metabolites may be delayed.

Hepatic Impairment

Since the liver is the primary site for the metabolism of Black Walnut's phytochemical components (like juglone), patients with Child-Pugh Class B or C impairment should be monitored closely. Reduced doses may be necessary to prevent the accumulation of quinone metabolites.

Elderly Patients

Clinical studies have not identified significant differences in response between elderly and younger patients. However, because older adults are more likely to have underlying cardiovascular disease, the risk of using epinephrine (required if a reaction occurs) must be weighed against the benefit of the extract.

• For Allergy Testing: This is performed exclusively in a clinic. You should avoid antihistamines (like loratadine or cetirizine) for at least 72 hours before the test, as they can mask the results.
• For Oral Supplements: Take with a full glass of water. It is often recommended to take Black Walnut on an empty stomach (1 hour before or 2 hours after meals) to maximize the absorption of its antifungal components, though taking it with food may reduce gastrointestinal upset.
• Storage: Liquid extracts must be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Oral capsules should be kept in a cool, dry place away from direct sunlight.

If you miss an immunotherapy appointment, contact your allergist immediately. Do not attempt to 'double up' the next dose, as this significantly increases the risk of anaphylaxis. If you miss an oral dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed one.

Signs of an overdose of Black Walnut (particularly oral ingestion) include:

• Severe abdominal pain
• Persistent vomiting or diarrhea
• Dizziness or fainting
• Skin rash or hives

In the event of an overdose, seek emergency medical attention or contact a Poison Control Center immediately. For injectable extracts, an 'overdose' usually manifests as a systemic allergic reaction, which requires immediate epinephrine administration.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop a prescribed immunotherapy regimen without medical guidance.

When Black Walnut is used as an allergenic extract for skin testing, local reactions are expected and occur in nearly all sensitive individuals. These include:

• Wheal and Flare: A raised, itchy bump (wheal) surrounded by redness (flare) at the site of application. This usually peaks within 20 minutes and subsides within a few hours.
• Local Pruritus: Intense itching at the injection or prick site.
• Gastrointestinal Upset: When taken orally, more than 10% of users report mild nausea or stomach cramps, likely due to the high tannin content of the walnut hulls.

• Delayed Local Reactions: Swelling and redness at the injection site that appears 6 to 24 hours after administration. This can be uncomfortable but is generally not dangerous.
• Headache: Some patients report mild tension-type headaches following immunotherapy.
• Fatigue: A general feeling of tiredness or malaise shortly after receiving an allergenic extract injection.
• Dermatitis: Topical contact with Black Walnut hulls can cause a brownish discoloration of the skin (due to juglone) and localized irritation.

• Urticaria (Hives): Generalized hives appearing on areas of the body away from the injection site.
• Angioedema: Swelling of the deeper layers of the skin, often around the eyes or lips.
• Rhinitis: Sneezing, runny nose, or nasal congestion triggered by the systemic introduction of the allergen.
• Lymphadenopathy: Swelling of the lymph nodes near the site of injection.

> Warning: Stop taking Black Walnut and call your doctor or emergency services immediately if you experience any of the following signs of anaphylaxis:

• Bronchospasm: Wheezing, chest tightness, or extreme difficulty breathing.
• Hypotension: A sudden drop in blood pressure, which may feel like severe lightheadedness or fainting.
• Laryngeal Edema: Swelling of the throat or a 'lump' in the throat that makes swallowing or breathing difficult.
• Tachycardia: A rapid, pounding heart rate often accompanied by a sense of doom.
• Cyanosis: Bluish tint to the lips, face, or fingernails indicating a lack of oxygen.

Prolonged oral use of Black Walnut (especially the hulls) is controversial. Some clinical literature suggests that long-term exposure to juglone, a known mutagen in certain laboratory models, could theoretically increase the risk of oral or esophageal cancers, although human data is sparse. Chronic use may also lead to a depletion of beneficial gut bacteria due to the extract's potent antimicrobial properties. Long-term immunotherapy, conversely, is generally well-tolerated and aims to induce long-term immunological tolerance.

While Black Walnut extracts do not always carry a specific 'boxed warning' in the same way as synthetic pharmaceuticals, all Allergenic Extracts are subject to stringent FDA labeling requirements regarding anaphylaxis.

Summary of Warning Content:

• This product can cause severe life-threatening systemic reactions, including anaphylaxis.
• It must only be administered by physicians diagnostic and treatment of allergic diseases.
• Patients must be observed for at least 30 minutes after injection.
• This product may not be suitable for patients with unstable asthma or those taking beta-blockers.

Report any unusual symptoms, especially those affecting your breathing or heart rate, to your healthcare provider immediately.

Black Walnut is a potent biological agent. Its use as an allergenic extract must be restricted to clinical settings where emergency equipment (including oxygen, IV fluids, and epinephrine) is immediately available. Patients must understand that even if they have tolerated previous doses, a systemic reaction can occur at any time.

FDA Warning for Allergenic Extracts:

"Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis. Patients should be informed of the risks and monitored for at least 30 minutes following administration. Physicians prescribing allergenic extracts should be prepared to treat anaphylaxis and should ensure that patients are appropriate candidates for immunotherapy."

• Anaphylaxis Risk: This is the most significant risk associated with Black Walnut. Risk factors include high sensitivity levels, a history of previous systemic reactions, and the use of the extract during peak allergy seasons.
• Asthma Exacerbation: Patients with poorly controlled or unstable asthma are at a significantly higher risk for severe, even fatal, bronchospasm when exposed to allergenic extracts. Asthma status must be assessed before every dose.
• Cardiovascular Stress: A systemic reaction to Black Walnut puts immense stress on the heart. Patients with pre-existing coronary artery disease or arrhythmias may be at higher risk for myocardial infarction (heart attack) during a reaction.
• Estrogenic Activity: Because Black Walnut is an Estrogen Receptor Agonist [MoA], individuals with hormone-sensitive conditions (such as breast cancer, uterine fibroids, or endometriosis) should use oral Black Walnut supplements with extreme caution.

If you are undergoing immunotherapy with Black Walnut, your doctor will monitor:

1. 1Peak Flow/Spirometry: To ensure lung function is stable before injection.
2. 2Injection Site: To check for excessively large local reactions which may predict a future systemic reaction.
3. 3Vital Signs: Blood pressure and heart rate monitoring if a reaction is suspected.
4. 4Liver Function Tests (LFTs): For patients taking high-dose oral supplements long-term, to ensure no hepatotoxicity from naphthoquinones.

Black Walnut itself does not typically cause sedation. However, if a systemic reaction occurs or if you are given antihistamines or epinephrine to treat a reaction, your ability to drive or operate machinery will be significantly impaired. It is recommended to wait at least 30-60 minutes after an injection before driving.

Alcohol should be avoided on the day of an immunotherapy injection. Alcohol can increase peripheral vasodilation (widening of blood vessels), which may accelerate the systemic absorption of the allergen and potentially worsen the severity of an allergic reaction.

There is no 'withdrawal' associated with stopping Black Walnut. However, if you stop immunotherapy prematurely, your allergy symptoms will likely return to their baseline severity. If you are taking oral Black Walnut for its estrogenic or antimicrobial properties, consult your doctor before stopping to ensure your condition is managed via alternative means.

> Important: Discuss all your medical conditions, especially heart disease and asthma, with your healthcare provider before starting Black Walnut.

• Non-Selective Beta-Blockers (e.g., Propranolol): These medications are contraindicated in patients receiving Black Walnut allergenic extracts. Beta-blockers can make an allergic reaction more severe and, crucially, can render epinephrine (the primary treatment for anaphylaxis) ineffective. This combination can lead to 'refractory anaphylaxis,' which is often fatal.

• Selective Beta-Blockers (e.g., Atenolol, Metoprolol): While slightly less risky than non-selective versions, they still pose a significant threat to the efficacy of emergency resuscitation. Use only if no alternative exists and under strict supervision.
• MAO Inhibitors (e.g., Phenelzine, Selegiline): These can potentiate the effects of epinephrine used to treat a reaction, leading to a hypertensive crisis (dangerously high blood pressure).
• Tricyclic Antidepressants (e.g., Amitriptyline): Similar to MAOIs, these can increase the cardiovascular response to epinephrine.

• Tamoxifen or Fulvestrant: Since Black Walnut acts as an Estrogen Receptor Agonist, it may theoretically compete with or interfere with the efficacy of estrogen-receptor antagonists used in breast cancer treatment.
• Antifungal Medications (e.g., Fluconazole): Black Walnut has inherent antifungal properties. Combining it with pharmaceutical antifungals may increase the risk of side effects, though data is limited.

• Other Tree Nuts: Cross-reactivity is common. If you are allergic to Black Walnut, you may also react to English Walnuts, pecans, and hickory nuts. Consuming these during immunotherapy can increase the 'allergic load' and trigger a reaction.
• High-Fat Meals: May increase the absorption of the fat-soluble components of Black Walnut (Vitamin A and Provitamin D2 precursors), potentially increasing the risk of vitamin toxicity if taken in very high doses.

• St. John’s Wort: May induce the metabolism of Black Walnut's phytochemicals, reducing their systemic levels.
• Phytoestrogens (e.g., Soy, Red Clover): Combining these with Black Walnut can have an additive estrogenic effect, which may be undesirable in certain health conditions.

• Skin Test Suppression: Antihistamines, certain antidepressants (TCAs), and even some acid reflux medications (H2 blockers like famotidine) can suppress the 'wheal and flare' response, leading to a false-negative result in allergy testing.
• Liver Enzymes: High doses of oral Black Walnut may cause transient elevations in ALT or AST levels.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list is vital for your safety during allergy treatment.

Black Walnut must NEVER be used in the following circumstances:

1. 1Severe, Uncontrolled Asthma: Patients with an FEV1 (Forced Expiratory Volume) consistently below 70% of predicted values are at an unacceptable risk for fatal bronchospasm during immunotherapy.
2. 2Recent Myocardial Infarction (Heart Attack): Within the last 3-6 months. The heart cannot tolerate the potential stress of an anaphylactic event or the epinephrine required to treat it.
3. 3History of Severe Anaphylaxis to Black Walnut: If a previous skin test or exposure resulted in near-fatal respiratory or cardiovascular collapse, further use of the extract is contraindicated.
4. 4Beta-Blocker Therapy: As noted in the interactions section, the inability to respond to epinephrine is a life-threatening contraindication.

• Pregnancy: While not an absolute contraindication for continuing a maintenance dose, starting a new course of Black Walnut immunotherapy during pregnancy is generally avoided due to the risk of fetal hypoxia (lack of oxygen) during a systemic reaction.
• Acute Infection or Fever: Testing or injections should be delayed until the patient is well, as an active immune system may be more prone to an exaggerated response.
• Autoimmune Disorders: Patients with active systemic lupus erythematosus (SLE) or rheumatoid arthritis may experience a flare-up of their condition when the immune system is stimulated by allergenic extracts.

Patients with a known allergy to English Walnut (*Juglans regia*) or Pecans (*Carya illinoinensis*) are highly likely to be cross-sensitive to Black Walnut. This is due to the high degree of structural homology (similarity) between the 2S albumin and vicilin-like proteins found in these species.

> Important: Your healthcare provider will evaluate your complete medical history, including your respiratory and cardiovascular health, before prescribing or administering Black Walnut.

• Pregnancy Category C: Animal reproduction studies have not been conducted with Black Walnut extracts. It is unknown whether the extract can cause fetal harm or affect reproduction capacity.
• Clinical Considerations: The primary risk during pregnancy is not the extract itself, but the potential for anaphylaxis. A severe allergic reaction in the mother can lead to uterine contractions and placental hypoperfusion (reduced blood flow to the fetus), resulting in fetal distress or loss. Most allergists will maintain a pregnant patient on a stable maintenance dose but will not increase the dose or start new therapy until after delivery.

It is not known whether the allergenic proteins or the phytochemical components of Black Walnut are excreted in human milk. Because many proteins are digested in the infant’s gut, the risk of sensitizing a nursing infant is considered low. However, breastfeeding mothers should consult their physician before using oral Black Walnut supplements, particularly due to the lack of data on juglone's effect on infants.

• Approval: Black Walnut is approved for diagnostic allergy testing in children of all ages.
• Safety: In children under 5, the risk-to-benefit ratio for immunotherapy is carefully considered, as young children may be unable to describe the early symptoms of a systemic reaction (e.g., itchy throat, nausea).
• Growth Effects: There is no evidence that allergenic extracts affect growth or development when used as directed.

• Cardiovascular Risk: Patients over 65 are at a higher risk for adverse outcomes if they experience a systemic reaction. The presence of underlying hypertension or heart disease makes the use of epinephrine more dangerous.
• Pharmacokinetics: Reduced renal clearance in the elderly may lead to slower elimination of the metabolic components of oral Black Walnut.

For patients with chronic kidney disease (CKD), the use of injectable extracts for testing is generally safe. However, oral consumption of Black Walnut hulls should be limited, as the kidneys are responsible for excreting the water-soluble metabolites of naphthoquinones. Accumulation could theoretically lead to increased systemic toxicity.

In patients with liver cirrhosis or hepatitis, the metabolism of phytosterols and quinones is impaired. This may enhance the Estrogen Receptor Agonist effects of the drug. Healthcare providers should monitor these patients for signs of estrogen excess (e.g., gynecomastia in men or abnormal bleeding in women) if using oral formulations.

> Important: Special populations require individualized medical assessment. Always inform your specialist of your pregnancy status or any organ impairment.

Black Walnut functions through two primary pathways:

1. 1Immunological Pathway: The extract contains specific allergenic proteins (such as Jug n 1 and Jug n 2). These proteins cross-link IgE antibodies on the surface of mast cells and basophils. This triggers the PLCγ (Phospholipase C gamma) signaling pathway, leading to an influx of calcium ions and the subsequent release of pre-formed mediators like histamine, as well as the synthesis of prostaglandins and leukotrienes.
2. 2Endocrine Pathway: As an Estrogen Receptor Agonist, the compound juglone (5-hydroxy-1,4-naphthoquinone) and various sterols bind to the ligand-binding domain of estrogen receptors. This complex translocates to the nucleus, where it binds to Estrogen Response Elements (EREs) on DNA, modulating the transcription of target genes involved in cellular growth and metabolic regulation.

• Onset of Action: For skin testing, the onset is rapid (5-10 minutes). For immunotherapy, the clinical effect (reduction in allergy symptoms) may take 6 to 12 months to become apparent.
• Duration of Effect: A skin test reaction lasts 2-6 hours. The immunological 'memory' created by successful immunotherapy can last for years or even a lifetime.
• Tolerance: In immunotherapy, the goal is to induce 'clinical tolerance' by shifting the immune response from a Th2 (allergic) profile to a Th1 or Treg (regulatory) profile, increasing the production of IgG4 antibodies which block IgE binding.

| Parameter | Value |

|---|---|

| Bioavailability | Moderate (Oral); Minimal (Topical/Diagnostic) |

| Protein Binding | >90% (Phytosterols) |

| Half-life | 2-4 hours (Proteins); 12-24 hours (Metabolites) |

| Tmax | 1-2 hours (Oral ingestion) |

| Metabolism | Hepatic (CYP-mediated reduction) |

| Excretion | Renal (60%), Fecal (40%) |

• Molecular Formula: Varies by component (Juglone: C10H6O3)
• Molecular Weight: Juglone: 174.15 g/mol; Proteins: 10-70 kDa
• Solubility: Proteins are water-soluble; Naphthoquinones are lipid-soluble.
• Description: The extract is a dark brown to black liquid with a characteristic phenolic odor.

Black Walnut is categorized as a Non-Standardized Food Allergenic Extract [EPC]. It shares this class with other tree nut extracts like Pecan and Cashew. It is also distinctively grouped with Estrogen Receptor Agonists [MoA] due to its specific phytochemical activity.